Jenica Thangathurai
Internal Medicine · Los Angeles, CANPI 1144683749
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,162 and has fallen 99.0% since, to $21 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $28.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Abbott$842
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$420
- Johnson & Johnson$415
- Amgen$219
- Pfizer$215
- plus $1K from 21 others
What the payments were for
- Grants$2506%
- Food & beverage$4,09391%
- Education$1553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 43 | $1,046 |
| Abbott | 29 | $842 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $420 |
| Johnson & Johnson | 18 | $415 |
| Amgen | 4 | $219 |
| Pfizer | 12 | $215 |
| Edwards Lifesciences | 1 | $187 |
| Novartis | 7 | $170 |
| Biotronik Inc. | 1 | $130 |
| Cvrx, Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| Chiesi USA, Inc. | 4 | $60 |
| Heartflow, Inc. | 1 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54 |
| AstraZeneca | 3 | $51 |
| Penumbra, Inc. | 1 | $48 |
| Novo Nordisk | 3 | $46 |
| Terumo Medical Corporation | 1 | $41 |
| Philips North America LLC | 2 | $41 |
| Lantheus Medical Imaging, Inc. | 1 | $36 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $30 |
| Biosense Webster, Inc. | 1 | $29 |
| United Therapeutics Corporation | 1 | $27 |
| Bayer | 1 | $24 |
| Medtronic | 1 | $20 |
| Teleflex LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,498 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Los Angeles
- William HardyLos Angeles$704K
- Soha DolatabadiLos Angeles$458K
- Matthew HerrmannLos Angeles$384K
- Koppany VisnyeiLos Angeles$287K
- Jaime BetancourtLos Angeles$286K
- William KingLos Angeles$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.